Company: ARTL
Filing Date: 2025-03-20
Form Type: S-8
Source: 0001640334-25-000439
Chunk: 1

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-20
Form: S-8
Chunk 1
---
ant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

<div align='center'>EXPLANATORY NOTE

REGISTRATION OF ADDITIONAL SECURITIES PURSUANT TO GENERAL INSTRUCTION E</div>

This Registration Statement on Form S-8 (the “Registration Statement”) is being filed to register an additional 484,155 shares of common stock of Artelo Biosciences, Inc. (the “Registrant”) reserved for issuance pursuant to future awards under the Registrant’s 2018 Equity Incentive Plan, as amended (the “2018 Plan”).

These additional shares of common stock are securities of the same class as other securities for which previous Registration Statements on Form S-8 were filed by the Registrant with the Securities and Exchange Commission (the “SEC”) on January 15, 2020 (File No. 333-235916), June 25, 2020 (File No. 333-239434), December 16, 2020 (File No. 333-251387), April 7, 2022 (File No. 333-264183), April 21, 2023 (File No. 333-271391), and March 29 2024 (File No. 333-278359) (collectively, the “Previous Registration Statements”). In accordance with General Instruction E of Form S-8, the contents of the Previous Registration Statements, including periodic reports filed after the Previous Registration Statements to maintain current information about the Registrant, are incorporated by reference into this Registration Statement.

<div align='center'>PART II

INFORMATION REQUIRED IN REGISTRATION STATEMENT</div>

Item 3. Incorporation of Documents by Reference.

The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the SEC:

| (1) | The Registrant’s Annual Report on Form 10-K (File No. 001-38951) for the fiscal year ended December 31, 2024 filed with the SEC on March 3, 2025;                                                                                                                                                                             |
| (2) | All other reports filed with the SEC pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) since the end of the fiscal year covered by the Registrant’s Annual Report referred to in (1